EMERYVILLE, Calif.--(BUSINESS WIRE)--Nov. 29, 2005--Nanomix Incorporated announced today that it has added Gregory T. Schiffman to the company's Board of Directors and appointed him Chairperson of the Nanomix Audit Committee. Mr. Schiffman is currently the Executive Vice President and CFO of Affymetrix, headquartered in Santa Clara, California with offices worldwide. Today, Affymetrix GeneChip(R) technology is considered the gold standard tool for analyzing complex genetic information and is used by hundreds of pharmaceutical, biotechnology, agrichemical, diagnostics and consumer products companies as well as academic, government and other non-profit research institutes to analyze the relationship between genes and human health.

Nanomix, leading nanotechnology company, is launching a portfolio of devices based on Sensation™ detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistries. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanodetection technology -- low power consumption, small form factor, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information. Nanomix is located in Emeryville, California. For additional information, please visit the Nanomix web site at www.nano.com.